Prenatal and Early Postnatal Exposure to Manganese Could Affect Cognitive Ability and Motor Control in Teens
Early-life exposure to the mineral manganese disrupts the way different areas of the brain involved in cognitive ability and motor control connect in teenagers, Mount Sinai researchers report in a study published in PLOS ONE in August.
This study is the first to link evidence of metal exposure found in baby teeth to measures of brain connectivity. Researchers found links between early-life manganese exposure and altered functional connectivity of brain areas that support cognitive and motor control, potentially leading to low IQ, attention disorders, and hyperactivity.
“These findings could inform prevention and intervention efforts to reduce these poor outcomes in adolescents exposed to high levels of manganese,” said Erik de Water, the first author and a postdoctoral fellow in the Department of Environmental Medicine and Public Health at the Icahn School of Medicine at Mount Sinai.
People can be exposed to manganese via air pollution, diet, drinking water, pesticides, and secondhand smoke. Researchers measured manganese concentrations in baby teeth to determine exposure during pregnancy, the first year of life, and early childhood.
They used functional magnetic resonance imaging (fMRI) scans to measure intrinsic functional connectivity of the brain in adolescents. Higher manganese concentrations in the first year of life were associated with increased intrinsic functional connectivity within cognitive control brain areas, but decreased connectivity between motor areas in adolescents.
About The Institute for Exposomic Research
The Institute for Exposomic Research at the Icahn School of Medicine at Mount Sinai is the world’s first research institute devoted to the intensive study of the exposome, or the totality of environmental influences on human health. The mission of the Institute is to understand how the complex mix of nutritional, chemical, and social environments affect health, disease, and development later in life and to translate those findings into new strategies for prevention and treatment. For more information, visit http://icahn.mssm.edu/exposomics.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with 48,000 employees working across eight hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 9,000 primary and specialty care physicians and 11 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report® “Best Hospitals” Honor Roll for 2024-2025.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.